![Tom Edward Pike](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tom Edward Pike
Président chez
Acd Pharmaceuticals AS
Profil
Tom Edward Pike is currently the Chairman of Credio as, Acd Pharmaceuticals AS, Europharma Apotek AS, Kaydence Pharma USA, and Director of Vingmed Holding AS and Vectron Biosolutions AS.
He previously held positions such as CEO & Director-Sales & Marketing at F.
Hoffmann-La Roche Ltd. and Hoffmann-La Roche, Inc., Chairman & CEO at Weifa ASA, and Chairman at Nykode Therapeutics ASA, ClanoTech AB, and Legemiddelindustrien.
He was also an Independent Director at Photocure ASA and NEL ASA, Director at Oncopeptides AB, Biosergen AS, and Kaydence Pharma AS, and Manager-Business Alliance at Roche Holding AG.
He started his career as a Partner at Neomed Management AS.
Mr. Pike obtained his undergraduate degree from the University of Aberdeen.
Postes actifs de Tom Edward Pike
| Sociétés | Poste | Début |
|---|---|---|
Acd Pharmaceuticals AS
 Acd Pharmaceuticals AS BiotechnologyHealth Technology Engages in biotechnology research and development work | Président | - |
Europharma Apotek AS
 Europharma Apotek AS Drugstore ChainsRetail Trade Operates as pharmacy | Président | - |
Credio as | Président | - |
Vectron Biosolutions AS
 Vectron Biosolutions AS BiotechnologyHealth Technology Develops microbial production processes for recombinant proteins | Directeur/Membre du Conseil | - |
Vingmed Holding AS
 Vingmed Holding AS Medical DistributorsDistribution Services Distributes cardiology, radiology, endoscopy, vascular surgery, intensive care, dialysis and thoracic surgery equipment | Directeur/Membre du Conseil | - |
Kaydence Pharma USA
 Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Président | - |
Anciens postes connus de Tom Edward Pike
| Sociétés | Poste | Fin |
|---|---|---|
| PHOTOCURE ASA | Directeur/Membre du Conseil | 10/06/2020 |
| NEL ASA | Directeur/Membre du Conseil | 01/11/2013 |
Neomed Management AS
 Neomed Management AS Investment ManagersFinance NeoMed utilizes a multi-stage investment approach and aims for growth of their portfolio firms. They invest at all development stages, from start-up to later stage growth financings. They have an investment horizon that spans three to five years. They focus on investments in the healthcare and life science sectors in the US and Europe, in particular in the Nordic region and Switzerland, Germany and the UK. Initial investments typically range from $2.5 million to $5 million. They normally invest with other venture capital partners that share a similar investment approach and vision. NeoMed seeks firms developing innovative products that address underserved medical needs in the following sectors: biotechnology drugs, diagnostics, pharmaceuticals, and medical devices and instruments. They look for intellectual property that is patent protected or benefits from other protective measures. The firm invests in firms with experienced management teams. | Private Equity Investor | 01/10/2008 |
| ░░░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Tom Edward Pike
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
19
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Photocure ASA
 Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Vingmed Holding AS
Vingmed Holding AS Medical DistributorsDistribution Services Distributes cardiology, radiology, endoscopy, vascular surgery, intensive care, dialysis and thoracic surgery equipment | Distribution Services |
University of Aberdeen
 University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NEL ASA
 NEL ASA Industrial MachineryProducer Manufacturing Manufactures and sells electrolyzers | Producer Manufacturing |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Weifa ASA
 Weifa ASA Pharmaceuticals: MajorHealth Technology Manufactures non-prescription and over-the-counter pharmaceutical products | Health Technology |
Neomed Management AS
Neomed Management AS Investment ManagersFinance NeoMed utilizes a multi-stage investment approach and aims for growth of their portfolio firms. They invest at all development stages, from start-up to later stage growth financings. They have an investment horizon that spans three to five years. They focus on investments in the healthcare and life science sectors in the US and Europe, in particular in the Nordic region and Switzerland, Germany and the UK. Initial investments typically range from $2.5 million to $5 million. They normally invest with other venture capital partners that share a similar investment approach and vision. NeoMed seeks firms developing innovative products that address underserved medical needs in the following sectors: biotechnology drugs, diagnostics, pharmaceuticals, and medical devices and instruments. They look for intellectual property that is patent protected or benefits from other protective measures. The firm invests in firms with experienced management teams. | Finance |
Credio as | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Nykode Therapeutics ASA
 Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
ClanoTech AB
 ClanoTech AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer and macular degeneration | Health Technology |
Legemiddelindustrien
 Legemiddelindustrien Pharmaceuticals: MajorHealth Technology Provides pharmaceutical industry services | Health Technology |
Acd Pharmaceuticals AS
Acd Pharmaceuticals AS BiotechnologyHealth Technology Engages in biotechnology research and development work | Health Technology |
Europharma Apotek AS
Europharma Apotek AS Drugstore ChainsRetail Trade Operates as pharmacy | Retail Trade |
Vectron Biosolutions AS
Vectron Biosolutions AS BiotechnologyHealth Technology Develops microbial production processes for recombinant proteins | Health Technology |
Kaydence Pharma AS
 Kaydence Pharma AS Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Kaydence Pharma USA
Kaydence Pharma USA Pharmaceuticals: MajorHealth Technology Develops menaquinone-7 for the treatment of vascular and tissue calcification-related diseases | Health Technology |
